BILL ANALYSIS
S3799
NEUTRALHealthy Start Reauthorization Act of 2026
S3799 (Healthy Start Reauthorization Act of 2026) has been assessed with a neutral outlook for investors. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
neutral
Market Sentiment
4/10
Impact Score
1
Sectors Impacted
Key Takeaways for Investors
The bill authorizes $145M/year for the Healthy Start Initiative, a maternal health grant program.
It is an authorization, not an appropriation; actual funding requires a separate spending bill.
No publicly traded healthcare companies are directly impacted by this legislation.
How S3799 Affects the Market
No market implications. The bill is a routine reauthorization of a federal grant program that does not create new procurement, tax credits, or regulatory changes for any public company.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | S3799 |
| Market Sentiment | neutral |
| Event Date | |
| Affected Sectors | Healthcare |
| Source | View on Congress.gov → |
Summary
The Healthy Start Reauthorization Act of 2026 (S. 3799) was reported favorably out of the Senate HELP Committee on June 17, 2026, and awaits floor action. It authorizes $145 million annually for FY2026-2030 for the Healthy Start Initiative, a maternal and child health grant program. This is an authorization, not an appropriation, and the direct financial impact on publicly traded healthcare companies is negligible.
Full AI Market Analysis
Sectors Impacted by S3799
Related Healthcare Legislation
Understand the Terms
Free — no credit card
Know which stocks S3799 moves — before the market does
HillSignal scores every bill, federal contract, and insider filing for market impact and emails you the high-conviction ones. Free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →